International Journal of Radiation Oncology, Biology, Physics 1991: Vol 20 Index

11 Pages·1991·2.2 MB·English

AUTHOR INDEX
Volume 20, 1991
Abe, M., 709, 1249 Bremner, J.C.M., 291 Curran Jr., W.J., 13, 101, 703, 835 Feldmann, H.J., 1017
Abernathy, R.S., 369 Brennan, K.M., 689 Curtis, $.B., 473 Ferguson, C., 909
Abitbol, A.A., 517 Brennan, M.F., 1229 Fessenden, P., 1099, 1145, 1147
Adams, G.E., 291, 643 Brenner, D.J., 181 Daly, N., 243, 343, 347 Fippin, L.F., 651
Adler, S., 1017 Brewster, L.J., 823 Daniel, W.E., 803 Fish, B.L., 333
af Trampe, E., 655 Bronn, D.G., 113 Danjoux, C.E., 509 Fitzpatrick, P., 423
Ago, C.T., 429 Brown, D.Q., 703 David, J.-M., 243 Fitzpatrick, P.J., 1377
Ahn, D.K., 1047 Brown, J.M., 457, 646, 987 Davies, B.M., 213 Flamant, F., 405
Ajani, J.A., 351 Broxmeyer, H.E., 525 Davis, L., 3, 13, 21 Flickinger, J.C., 1287, 1325
Akine, Y., 1215 Brunel, P., 965 Davis, R.L., 651 Flynn, D.F., 1363
Albano, M., 405 Bugat, R., 347 de Cremoux, H., 1183 FNCLCC, 1183
Alberti, W., 1087 Burleson, W.D., 1347 Deisseroth, A.B., 1047 Forman, J.D., 1317
Algan, O., 1053 Burman, C., 127, 823 Delanian, S., 965 Fossa, $.D., 1379
Anderson, R.L., 479 Burnett, A.K., 1219 DeLaPaz, R.L., 689 Fossella, F.V., 351
Anderson, W., 697 Butturini, A., 631, 645 DeLuca, A.M., 697 Fowble, B.L., 105
Andrews, J.C., 555 Byhardt, R.W., 7 Demidecki, A.J., 715 Fowler, J.F., 169, 295, 1380
Arbit, E., 787 De Paula, F., 439 Fox, M.G., 661
Arcangeli, G., 439 DeSanctis, A.J., 509 Fraass, B.A., 1309
Arcangeli, G., 439 Calais, G., 677 Descamps, P., 677 Frankel, K.A., 689, 881
Arimizu, N., 797 Calkins, A.R., 661 Deurloo, I.-K.K., 1281 Franzen, L., 1093
Armstrong, J.G., 787 Campbell, O., 809 Devergie, A., 397 Frazier, C., 953
Arriagada, R., 1183 Canal, P., 343, 347 DeWeese, T.L., 803 Freeman, C.R., 921, 1331
Artwohl, J.E., 567 Carey, M., 1067 Dewhirst, M.W., 1099, 1109, 1117 Friedman, W.A., 891
Asbell, S., 53, 65, 953 Carmichael, J., 197 Dische, S., 147, 581 Frotz, P., 1061
Attal, M., 397 Carter, R., 1219 Dobelbower Jr., R.R., 113 Fu, K.K., 327, 1191
Awan, A.M., 413 Cassady, J.R., 1177 Dobrowsky, E., 239, 275 Fuks, Z.Y., 823, 1075
Awschalom, M., 1341 Castro, J.R., 761 Dobrowsky, W., 239
Ayyangar, K.M., 121, 179 CEBI trialists, 1183 Doornbos, J.F., 781 Gale, M., 247
Azarnia, N., 7 Cebulska-Wasilewska, A., 311 Dorie, M.J., 311 Gale, R.P., 631, 645
Aziz, H., 173 Chambers, J.T., 1305 Douillard, J.-Y., 1183 Gandara, D.R., 1047
Chambers, S.K., 1305 Douple, E.B., 739 Garrigues, J.M., 575
Bachaud, J.-M., 243, 343, 347 Chandler, R., 21 Dubois, J.B., 575 Garrity, J.A., 791
Bagshaw, M.A., 551 Chaney, E.L., 843 Durand, R.E., 253, 271 Geer, L.Y., 613
Baillet, F., 965 Chapman, M., 287 Durand, S., 405 Geldof, A.A., 981
Bains, M., 787 Chapuis, J.-C., 373 Dworzanin, L.M., 555 Gemer, L.S., 587
Banks, P.M., 791 Chassagne, D., 405 Genin, J., 405
Baretton, G., 1273 Chen, M.G., 791 Earle, J.D., 791 Gerbaulet, A., 405
Barkley Jr., H.T., 945 Chen, M.-S., 915 Ebihara, S., 1215 Gerhardsson, A., 1317
Barnes, M., 697 Cheng, A.Y., 613 Edwards, M.S.B., 651, 757 GETCB, 1183
Barnett, T.A., 1145, 1147 Chiu-Tsao, S.-t., 1075 Egawa, S., 1215 Giannarelli, D., 439
Becker, H.D., 1061 Chodak, G.W., 413 Eichling, J., 627 Gibbs, F., 73
Beikirch, A., 287 Choi, N.C., 1137 Eifel, P.J., 910 Gill, S.S., 599
Belanger, C., 397 Chu, J.C.H., 141 Ellerbroek, N.A., 351, 945 Gillette, E.L., 463
Belfi, C.A., 497 Chuang, F.Y.S., 881 Elmaleh, D., 593 Gillin, M.T., 815
Belli, J.A., 910 Coffey, R.J., 1287 Emami, B., 7, 73, 531, 1099, 1109, Girinsky, T., 397
Benassi, M., 439 Coia, ©., 1191 1117 Glatstein, E., 389
Bennett, M.J., 369 Coia, L.R., 29, 45, 81, 95, 621, 667 Engstrom, P.F., 29 Glover, G., 581
Bentzen, S.M., 1197 Constine, L.S., 447, 897 Ensminger, W.D., 555, 1381 Gluckman, E., 397
Berg, D., 347 Contesso, G., 405 Erlanson, M., 1093 Goldwein, J.W., 45
Bhandare, L.T., 121 Cooley, G., 815 Ettinger, D., 953 Gonzalez-Arias, S., 517
Bhandare, N., 179 Cooper, J.S., 5, 13, 419, 429 Evans, M.D.C., 921 Goodman, R.L., 105
Binns, W.R., 613 Com, B.W., 1363 Evans, M.J., 303, 307 Gooya, J.M., 303, 307
Bissonette, D.J., 1287 Corry, P., 1099, 1109 Evans, R.G., 207, 587 Gospodarowicz, M., 383
Blitzer, P.H., 21 Cosmatos, D., 429 Evans, S.M., 703 Gould, M.N., 295
Bogardus, C.R., Jr., 1171 Coss, R.A., 59 Graham, M.L., 613
Boisserie, G., 965 Cosset, J.M., 397 Faber, L.P., 247 Grau, C., 265
Bonomi, P., 247 Coughlin, C.T., 429, 739 Fabrikant, J.I., 689, 881 Greenberg, H.S., 1309
Bortin, M.M., 631, 645 Counsell, C.J.R., 291 Fairchild, C.R., 361 Grdina, D.J., 733
Boussin, G., 243 Cowan, K.H., 361 Farah, R., 413 Grigsby, P.W., 627, 933
Bova, F.J., 891 Cox, J.D., 7, 1191, 1375, 1383 Fass, D.E., 787, 823 Gritzmann, N., 239
Brada, M., 599 Cox, R.S., 1145, 1147 Faulkner, L.A., 203 Grunert, P., 621
Brady, L.W., 809, 1383 Cribbs, R., 987 Fazekas, J.T., 13 Guedea, F., 777
Braun, O., 239 Crooijmans, R.P.M.A., 1235 Feeley, M.M., 509 Guerra, J., 1331
AUTHOR INDEX
Volume 20, 1991
Abe, M., 709, 1249 Bremner, J.C.M., 291 Curran Jr., W.J., 13, 101, 703, 835 Feldmann, H.J., 1017
Abernathy, R.S., 369 Brennan, K.M., 689 Curtis, $.B., 473 Ferguson, C., 909
Abitbol, A.A., 517 Brennan, M.F., 1229 Fessenden, P., 1099, 1145, 1147
Adams, G.E., 291, 643 Brenner, D.J., 181 Daly, N., 243, 343, 347 Fippin, L.F., 651
Adler, S., 1017 Brewster, L.J., 823 Daniel, W.E., 803 Fish, B.L., 333
af Trampe, E., 655 Bronn, D.G., 113 Danjoux, C.E., 509 Fitzpatrick, P., 423
Ago, C.T., 429 Brown, D.Q., 703 David, J.-M., 243 Fitzpatrick, P.J., 1377
Ahn, D.K., 1047 Brown, J.M., 457, 646, 987 Davies, B.M., 213 Flamant, F., 405
Ajani, J.A., 351 Broxmeyer, H.E., 525 Davis, L., 3, 13, 21 Flickinger, J.C., 1287, 1325
Akine, Y., 1215 Brunel, P., 965 Davis, R.L., 651 Flynn, D.F., 1363
Albano, M., 405 Bugat, R., 347 de Cremoux, H., 1183 FNCLCC, 1183
Alberti, W., 1087 Burleson, W.D., 1347 Deisseroth, A.B., 1047 Forman, J.D., 1317
Algan, O., 1053 Burman, C., 127, 823 Delanian, S., 965 Fossa, $.D., 1379
Anderson, R.L., 479 Burnett, A.K., 1219 DeLaPaz, R.L., 689 Fossella, F.V., 351
Anderson, W., 697 Butturini, A., 631, 645 DeLuca, A.M., 697 Fowble, B.L., 105
Andrews, J.C., 555 Byhardt, R.W., 7 Demidecki, A.J., 715 Fowler, J.F., 169, 295, 1380
Arbit, E., 787 De Paula, F., 439 Fox, M.G., 661
Arcangeli, G., 439 DeSanctis, A.J., 509 Fraass, B.A., 1309
Arcangeli, G., 439 Calais, G., 677 Descamps, P., 677 Frankel, K.A., 689, 881
Arimizu, N., 797 Calkins, A.R., 661 Deurloo, I.-K.K., 1281 Franzen, L., 1093
Armstrong, J.G., 787 Campbell, O., 809 Devergie, A., 397 Frazier, C., 953
Arriagada, R., 1183 Canal, P., 343, 347 DeWeese, T.L., 803 Freeman, C.R., 921, 1331
Artwohl, J.E., 567 Carey, M., 1067 Dewhirst, M.W., 1099, 1109, 1117 Friedman, W.A., 891
Asbell, S., 53, 65, 953 Carmichael, J., 197 Dische, S., 147, 581 Frotz, P., 1061
Attal, M., 397 Carter, R., 1219 Dobelbower Jr., R.R., 113 Fu, K.K., 327, 1191
Awan, A.M., 413 Cassady, J.R., 1177 Dobrowsky, E., 239, 275 Fuks, Z.Y., 823, 1075
Awschalom, M., 1341 Castro, J.R., 761 Dobrowsky, W., 239
Ayyangar, K.M., 121, 179 CEBI trialists, 1183 Doornbos, J.F., 781 Gale, M., 247
Azarnia, N., 7 Cebulska-Wasilewska, A., 311 Dorie, M.J., 311 Gale, R.P., 631, 645
Aziz, H., 173 Chambers, J.T., 1305 Douillard, J.-Y., 1183 Gandara, D.R., 1047
Chambers, S.K., 1305 Douple, E.B., 739 Garrigues, J.M., 575
Bachaud, J.-M., 243, 343, 347 Chandler, R., 21 Dubois, J.B., 575 Garrity, J.A., 791
Bagshaw, M.A., 551 Chaney, E.L., 843 Durand, R.E., 253, 271 Geer, L.Y., 613
Baillet, F., 965 Chapman, M., 287 Durand, S., 405 Geldof, A.A., 981
Bains, M., 787 Chapuis, J.-C., 373 Dworzanin, L.M., 555 Gemer, L.S., 587
Banks, P.M., 791 Chassagne, D., 405 Genin, J., 405
Baretton, G., 1273 Chen, M.G., 791 Earle, J.D., 791 Gerbaulet, A., 405
Barkley Jr., H.T., 945 Chen, M.-S., 915 Ebihara, S., 1215 Gerhardsson, A., 1317
Barnes, M., 697 Cheng, A.Y., 613 Edwards, M.S.B., 651, 757 GETCB, 1183
Barnett, T.A., 1145, 1147 Chiu-Tsao, S.-t., 1075 Egawa, S., 1215 Giannarelli, D., 439
Becker, H.D., 1061 Chodak, G.W., 413 Eichling, J., 627 Gibbs, F., 73
Beikirch, A., 287 Choi, N.C., 1137 Eifel, P.J., 910 Gill, S.S., 599
Belanger, C., 397 Chu, J.C.H., 141 Ellerbroek, N.A., 351, 945 Gillette, E.L., 463
Belfi, C.A., 497 Chuang, F.Y.S., 881 Elmaleh, D., 593 Gillin, M.T., 815
Belli, J.A., 910 Coffey, R.J., 1287 Emami, B., 7, 73, 531, 1099, 1109, Girinsky, T., 397
Benassi, M., 439 Coia, ©., 1191 1117 Glatstein, E., 389
Bennett, M.J., 369 Coia, L.R., 29, 45, 81, 95, 621, 667 Engstrom, P.F., 29 Glover, G., 581
Bentzen, S.M., 1197 Constine, L.S., 447, 897 Ensminger, W.D., 555, 1381 Gluckman, E., 397
Berg, D., 347 Contesso, G., 405 Erlanson, M., 1093 Goldwein, J.W., 45
Bhandare, L.T., 121 Cooley, G., 815 Ettinger, D., 953 Gonzalez-Arias, S., 517
Bhandare, N., 179 Cooper, J.S., 5, 13, 419, 429 Evans, M.D.C., 921 Goodman, R.L., 105
Binns, W.R., 613 Com, B.W., 1363 Evans, M.J., 303, 307 Gooya, J.M., 303, 307
Bissonette, D.J., 1287 Corry, P., 1099, 1109 Evans, R.G., 207, 587 Gospodarowicz, M., 383
Blitzer, P.H., 21 Cosmatos, D., 429 Evans, S.M., 703 Gould, M.N., 295
Bogardus, C.R., Jr., 1171 Coss, R.A., 59 Graham, M.L., 613
Boisserie, G., 965 Cosset, J.M., 397 Faber, L.P., 247 Grau, C., 265
Bonomi, P., 247 Coughlin, C.T., 429, 739 Fabrikant, J.I., 689, 881 Greenberg, H.S., 1309
Bortin, M.M., 631, 645 Counsell, C.J.R., 291 Fairchild, C.R., 361 Grdina, D.J., 733
Boussin, G., 243 Cowan, K.H., 361 Farah, R., 413 Grigsby, P.W., 627, 933
Bova, F.J., 891 Cox, J.D., 7, 1191, 1375, 1383 Fass, D.E., 787, 823 Gritzmann, N., 239
Brada, M., 599 Cox, R.S., 1145, 1147 Faulkner, L.A., 203 Grunert, P., 621
Brady, L.W., 809, 1383 Cribbs, R., 987 Fazekas, J.T., 13 Guedea, F., 777
Braun, O., 239 Crooijmans, R.P.M.A., 1235 Feeley, M.M., 509 Guerra, J., 1331
Guse, C., 65 Isaacson, S., 53 Laplanche, A., 1183 Maroun, J., 509
Guyotat, D., 397 Itami, J., 797 Laramore, G.E., 13 Martenson Jr., J.A., 791
Itami, M., 797 Larson, D.A., 757, 1325 Martin, L., 509
Habrand, J.L., 405 Ito, H., 927 Lartigau, E., 581 Martini, B., 787
Hahn, G.M., 479 La Vigne, M.L., 1309 Martz, K., 53, 87, 95, 105
Hahn, P., 1067 Jacobs, J.R., 21 Lawrence, T.S., 377, 555, 1381 Martz, K.L., 1363
Haie, C., 405 Jacobsson, H., 1297 Lax, I., 655 Mattson, K., 973
Halberg, F.E., 651 Janjan, N., 429, 815 Leblond, V., 397 Maruyama, Y., 1353
Hall, E.J., 181 Javed Afzal, S.M., 473 Le Bourgeois, J.P., 397 Matthews, J., 1255
Hanks, G.E., 3, 29, 45, 81, 87, 95, Jen, Y.-M., 1243 le Chevalier, T., 1183 Maulard, C., 965
101, 105, 141, 153, 667, 703, Jenkin, R.D.T., 639 LeCouteur, R.A., 463 Maylin, C., 965
835, 1383 Jiang, S.Z., 1273 Lee, C., 73 McChesney Gillette, S.L., 463
Hansen, P.V., 339 Johansen, L.V., 1197 Lee, C.K.K., 1009 McGowan, K.M., 307
Hanson, J.M., 1053 Johnke, R.M., 369 Lee, E.R., 1145, 1147 McKenna, D.S., 281
Harder, D., 1087 Jouet, J.P., 397 Lee, F., 447 McKusick, K.A., 593
Harms, W.B., 853 Julia, A.M., 343, 347 Lee, M.S., 247 McNee, S., 1219
Harrell, J.P., 303, 307 Le Floch, O., 677 McShan, D.L., 1309, 1317
Harris, J.R., 177 Kagiya, T., 1249 Leibel, S.A., 65, 823, 953, 1383 Medendorp, S.V., 497
Harrison, L.B., 787, 823 Kal, H.B., 1235 Leichner, P.K., 65, 953 Mehta, D.M., 1207
Hartmann, G.H., 517 Kallman, R.F., 227, 311 Leith, J.T., 203 Mehta, M.P., 1053
Harwell, S., 447 Kamen, C., 113 Lemmon, M.J., 457, 646 Menache, L., 910
Hasegawa, T., 1001 Kamikonya, N., 685 Lerch, I., 419 Mendelew, K., 921
Hashimoto, S., 927 Kaneko, T., 797 Leung, W.-M., 915 Mendenhall, W.M., 777
Hassanein, R., 587 Kaplan, I., 551 Levendag, P.C., 1281 Mendoza, M., 1053
Haulk, T., 953 Kapp, D.S., 479, 551, 1099, 1109, Levin, A.B., 1053 Menegay, H.J., 281
Hawliczek, R., 621 1117, 1145, 1147 Levin, V.A., 651 Mercer, L.J., 567
Hazuka, M.B., 803 Karim, A.B.M.F., 1207 Levine, R.L., 1053 Meredith, R.F., 357
Hegarty, T.J., 1309 Karlsson, U.L., 1347 Levitt, S.H., 1009 Merrick III, H.W., 113
Heimburger, D.K., 377, 1317 Kavanau, K.S., 473 Levy, R.P., 881 Meyer-Schwickerath, M
Helfand, S., 703 Kelly, K., 1079 Lewin, A.A., 517 Mian, T.A., 1347
Hendry, J.H., 1243 Keng, P.C., 373, 447 Leybovich, L., 531 Micaily, B., 809
Henle, K.J., 1263 Kennamer, D., 910 Lichter, A.S., 555, 1317 Michallet, M., 397
Henriksson, R., 1093 Kennedy, K.A., 259 Lin, F., 587, 915 Micheli, A., 439
Herbert, S.H., 835 Kessler, M., 881 Lin, P.-S., 1039 Michel-Langlet, P., 965
Herman, K.-P., 1087 Keus, R.B., 1207 Lindegaard, J.C., 1023 Michelson, S., 203
Herman, M.G., 635 Kier, R., 1305 Ling, C.C., 823 Mikata, A., 797
Herman, T.S., 723, 1031, 1099, Kim, G.E., 541 Linstadt, D.E., 757, 761 Mikkelsen, R.B., 1039
1109, 1117 Kim, R.Y., 357 Lipsett, J., 429 Miller, E., 1380
Herpst, J., 953 Kimler, B.F., 207 Littbrand, B., 1093 Million, R.R., 777
Herve, P., 397 Kinsella, T.J., 295, 389, 697, 1053, Liu, F.-F., 423 Milpied, N., 397
Hickson, I.D., 197 1380 Lo, E.H., 689 Minehan, K.J., 791
Hill, C.K., 1341 Kinzie, J.J., 803 Lockett, M.A., 933 Miser, J.S., 389
Hill, R.P., 383 Kirkbride, P., 909 Loffler, E., 1061 Miura, T., 685
Hirst, V.K., 987 Kitakabu, Y., 709, 1249 Lofroth, P.-O., 1093 Mohan, R., 127, 823
Hisanaga, Y., 1249 Kittle, C.F., 247 Lohrbach, A., 1145, 1147 Mohiuddin, M., 37, 1191
Hishikawa, Y., 685 Kivisaari, L., 973 Loven, D.P., 369 Molls, M., 1017
Hitchon, P.W., 781 Klein, J.L., 65, 953 Loverock, L.T., 771 Monson, T.P., 1263
Holden, S.A., 723, 1031 Knox, S.J., 1363 Lowry, L.D., 21 Montana, G.S., 87
Holmes, T., 859 Komaki, R., 351 Lu, L., 525 Moormeier, J., 413
Holoye, P.Y., 351 Komarnicky, L.T., 53, i21, 179 Lundell, G., 655 Moser, C., 809
Holsti, L.R., 973 Konski, A.A., 113 Lunsford, L.D., 1287 Moulder, J.E., 213, 333
Holt, J.A., 567 Kopher, K., 953 Lustig, R.A., 101 Mountain, C., 945
Hommel, D.J., 803 Kovacs, C.J., 303, 307 Luu, Y.H., 987 Mulcahy, R.T., 295
Hong, C.-H., 915 Kovalic, J.J., 933 Lyman, J.T., 881 Murphy, S.A., 369
toogenhout, J., 1235 Krag, D.N., 479 Lyons, J.C., 541 Murray, K.J., 815
Hoogenraad, W.J., 1207 Krall, J.M., 81, 101 Murray, M.J., 909
Hoopes, P.J., 739 Kramer, S., 21 Maasilta, P., 433, 973 Murray, W.J., 909
Hopwood, L.E., 213 Kumagaya, H., 927 Mackie, T.R., 859 Muskalla, K., 1087
Hordijk, G.J., 1207 Kun, L.E., 897 MacPhail, S., 221 Mychalczak, B., 787
Hornback, N.B., 525 Kurisu, K., 685 Maher, E.J., 1369 Myerson, R.J., 73, 1099, 1109, 1117
Horowitz, M.E., 389 Kurtin, P.J., 791 Maki, E., 423
Horsman, M.R., 291 Kutcher, G.J., 127, 823 Mansfield, C.M., 121, 179 Nagle, W.A., 1263
Houdek, P.V., 517 Kwok, T.T., 315 Mansouri, A., 1263 Nakayama, T., 927
Housset, M., 965 Maraninchi, D., 397 Naslund, I., 1297
Huart, J., 965 LaCreta, F., 703 Marcial, L.V., 81 Neff, J., 587
Hughes, C.S., 259 Lakeman, R.F., 1281 Marcial, V.A., 13, 21, 81, 179, 1191 Nerlinger, R.E., 1255
Hunt, M.A., 823 Lam, K.N., 327 Marcus Jr., R.B., 901 Neubauer, J., 621
Hussey, D.H., 781 Lanciano, R.M., 81, 95, 667, 835 Markiewicz, D., 153 Newell, K., 275
Hwang, C.C., 141 Lansac, J., 677 Marks, G., 37 Ngo, F.Q.H., 497
Nickles, R.J., 1053 Regine, W.F., 121, 179 Shalev, S., 1067 Tenforde, T.S., 473
Nielsen, O.S., 1023 Reichgelt, B.A., 1207 Shen, R.-N., 525 Ten Haken, R.K., 555, 1309, 1317,
Niroomand-Rad, A., 605 Reiffers, J., 397 Sherman, N.E., 563 1341
Nishiguchi, I., 927 Rhee, J.G., 1009 Sherouse, G.W., 843 Tepper, J.E., 843
Nishimoto, S.-I., 1249 Rhodes, T., 217 Shewach, D.S., 377 Terhaard, C.H.J., 1207
Nishizawa, K., 593 Rice, G.C., 479 Shibamoto, Y., 709, 1249 Terrill, R., 697
Nori, D., 787, 1229 Rich, T.A., 351, 563 Shidnia, H., 525 Thames, H.D., 1197
Rio, B., 397 Shigeratsu, N., 927 The Radiation Therapy Oncology
Ogata, H., 797 Ritter, M.A., 295 Shimokawa, K., 1249 Group, 1191
Ogino, T., 1215 Riyami, B.M.S., 1219 Shin, K.H., 7 Theeuwes, A.G.M., 1235
Ohyaina, W., 1215 Roach III, M., 1047 Shiu, M.H., 1229 Thomas, D.G.T., 599
Okunieff, P., 593 Roberts, D.W., 739 Shrivastava, P., 1099, 1109, 1117 Thomas, R.J., 771
Oleson, J.R., 1143 Robertson, A.G., 1219 Shupak, K., 1229 Thornton, A.F., Jr., 1309
Ono, K., 709 Rockwell, S., 259 Siemann, D.W., 287, 373, 447 Tjoh-Heslinga, R., 1207
Order, S.E., 65, 661, 953, 1383 Rodriguez, R., 1380 Simpkin, D., 859 Tokita, N., 1215
Ortiz, H., 1191 Roizin-Towle, L., 751 Sindelar, W.£., 697 Trott, K.-R., 905
Orton, C.G., 1131, 1379 Roman, T.N., 921 Skov, K., 221 Trowbridge, D.R., 587
Osborn, J., 1009 Rosenman, J., 843 Slater, J.D., 945 Tsukiyama, I., 1215
Oswald, M.J., 945 Rosenshein, N.B., 661 Slessinger, E., 627 Tu, C.-P., 915
Overgaard, J., 265, 1197 Rosenstein, M., 1075 Slotman, B.J., 981 Tupchong, L., 21, 1255
Roszinski, S., 1273 Smalley, S.R., 207 Twentyman, P.R., 217
Pajak, T.F., 13, 21, 953, 1191, 1383 Roth, J.A., 351, 945 Smith, H., 1075
Pakuris, E., 1383 Rotman, M., 173 Smith, N.N., 59 Uno, K., 797
Pansadoro, V., 439 Rowland, K., 247 Smith, V., 1325 Urtasun, R., 53
Papa, G., 203 Roy, J., 1075 Snow, J.B., 21
Parsons, J.T., 777 Rozental, J.M., 1053 Socie, G., 397 Vaheri, A., 973
Pastyr, O., 1061 Rubin, P., 1, 13, 387, 447, 649, 913, Soffen, E.M., 141 Valdagni, R., 1382
Patel, P., 1353 1191 Solin, L.J., 105, 835 Valk, P.E., 689
Paul, A.R., 29 Rubinstein, L., 939 Song, C.W., 541, 1001, 1009 Valone, F.H., 1047
Payne, D., 423 Ruffie, P., 1183 Sorensen, D., 339 VanGilder, J.C., 781
Pejovic, M.H., 405 Rugg, T., 581 Souhami, L., 921, 1331 van Kersen, I., 479
Perez, C.A., 7, 73, 627, 903, 933, Ruifrok, A.C.C., 1281 Speiser, B., 1133 Van Lancker, M., 1125, 1381
981, 1383 Rush, S., 429 Spencer, S.A., 357 Vannier, M.W., 613
Perez, E.A., 1047 Ryan, T.P., 739, 1099, 1109, 1117 Spielmann, M., 405 VanWinkle, T., 703
Perez-Tamayo, C., 1317 Spittle, M.F., 771 Varnes, M.E., 281
Peschel, R.E., 1305 Sack, H., 1017 Stafford, P.M., 29, 835 Vegesna, V., 997
Peters, G.E., 357 Sag: *, S.M., 771 Stauffer, P., 531, 1099, 1109, 1117 Venzon, D., 389
Peters, L.J., 563, 945 Saikawa, M., 1215 Stedman, T., 1039 Vernant, J.P., 397
Phillips, A., 247 Sailer, S.L., 843 Steinberg, G.K., 689 Viggars, D., 1067
Phillips, M.H., 689, 881 Salonen, E.-M., 973 Steinfeld, A.D., 419 Vigliotti, A.P., 781
Phillips, T.L., 53, 761, 1047, 1383 Salter, M.M., 357 Stephens, S., 357 Visser, A.G., 1281
Pico, J., 397 Samulski, T.V., 1099, 1109, 1117 Stetz, J., 21 Vitu, L., 677
Pignon, J.-P., 1183 Sanders, R., 581 Stevenson, R.D., 1219 Vogelzang, N.J., 413
Pirro, J.P. 751 Sapareto, S.A., 1099, 1109, 1117 Stewart, F.A., 319 Volk, D.M., 213
Pla, C., 921, 1331 Sapozink, M., 1099, 1109, 1117 Stillwagon, G.B., 65, 953 Vonderheid, E.C., 809
Pla, M., 1331 Saral, R., 635 Stitt, J.A., 1347 Vriesendorp, H.M., 635
Podgorsak, E.B., 921, 1331 Sarrazin, D., 405 Stone, H.B., 987
Poljak, A., 689 Sasai, K., 709, 1249 Storme, G., 1125, 1381 Wagner, Th., 1273
Pothman, B., 1087 Sathiaseelan, V., 531 Strassl, H., 239 Walker-Andrews, S.C., 555
Powers, B.E., 463 Saunders, M.I., 581 Straube, W., 531 Waller, B., 389
Prados, M.B., 651, 757 Sause, W.T., 429 Strauss, H.W., 593 Wallner, K.E., 489, 1075
Prionas, $.D., 1099, 1109, 1117 Saw, C.B., 135 Strohbehn, J.W., 739 Walton, L.A., 939
Pryde, P.G., 567 Scheiber, V., 239 Stutzman, C.D., 1347 Wang, J., 1249
Pujol, H., 575 Schell, M.C., 1325 Suit, H.D., 593 Wang, T.-R., 915
Purdy, J., 627, 853 Schelper, R.L., 781 Suntharalingam, N., 135 Wannenmacher, M., 1061
Purl, S., 247 Schifeling, D., 113 Sutherland, R.M., 315 Wara, W.M., 651, 757
Schmidt, W.F.O., 621 Warde, P., 423
Quiet, C.A., 413, 733 Schmidt-Ullrich, R., 1039, 1079 Tabor, P., 1087 Warren, W., 247
Quinn, P., 203 Schoenberg, H., 413 Taifu, L., 875 Warrington, A.P., 599
Quoix, E., 1183 Schoeppel, S.L., 1317 Tait, R.C., 1219 Wasserman, T., 195
Schrader, D.A., 1053 Takahashi, M., 1249 Wasserman, T.H., 1383
Raaphorst, G.P., 509 Schraube, P., 1061 Tamaru, J.-I., 797 Waterman, F.M., 1099, 1109, 1117,
Raghavan, D., 233 Schupak, K.D., 489 Taniguchi, M., 685 1255
Rao, B.R., 981 Schwaab, G., 405 Tannock, I., 195, 275 Weaver-McClure, L., 389
Rapacchietta, D., 227 Schwachofer, J.H.M., 1235 Tarayre, M., 1183 Weichselbaum, R.R., 413, 733
Recht, A., 177 Schwade, J.G., 517 Taylor, B.W., 1363 Weiss, C., 1273
Reckwerdt, P., 859 Scott, C.B., 21, 73 Taylor, J.H., 739 Wen, B-C., 781
Reddy, E., 587 Selim, H., 1191 Taylor IV, S.G., 247 Weppelmann, B., 357
Reddy, S., 247 Serago, C.F., 517 Teicher, B.A., 723, 1031 Werner, S., 655
Wessels, B.W., 715 Withrow, S.J., 463 Wright, K.A., 217 Yan, X.W., 715
West, C.M.L., 1243 Wollner, I.S., 555 Wu, A., 1079, 1325 Yanke, B.R., 1309
Wheeler, R.H., 357 Won, M., 667 Wu, B., 525 Yoshizumi, T., 1215
Wiedemann, G., 1273 Wong, J.W., 613
Williams, L.E., 715 Wong, J.Y.C., 715
Wilson, C.B., 651 Woo, S.Y., 479 Yadusky, A., 939 Zaghloul, M.S., 227
Wilson, J.F., 815 Wood, P.J., 291 Yaes, R.J., 1353 Zhou, L., 1249
Withers, H.R., 997 Woodruff, K.H., 689 Yan, R., 271 Zwicker, R.D., 1079
KEY WORD/SUBJECT INDEX
Volume 20, 1991
Bone sarcoma 761 Transitional cell 413
Boost 177 Uterine cervix 81
Electron 121 CDDP 343
Acid pH 275 Brachytherapy 81, 135, 181, 405, 587, 627, Cell(s)
Acidic environment 287 677, 859, 915, 965, 1075, 1079, 1125, Acutely hypoxic 709
Acquired immunodeficiency syndrome 1229, 1353 Human carcinoma 751
(AIDS) 803 High dose rate 921, 927 Hypoxic 147, 271
Acromegaly 655 Intracavitary 927 Rodent 751
Acute 327 Brain 689, 739 Squamous 21
Acutely hypoxic cell 709 Metastases 53, 1287 Sorting 271
Adjuvant therapy 21 Tumor(s) 757, 815, 1053, 1287 V79 221
Administration Brainstem 757 V79 Chinese hamster 1341
i.p. 997 Breast Cell-cell interactions 315
i.v. 997 Cancer 105, 177 Cervical cancer 667, 915
Adults 757 Definitive irradiation 105 Recurrent 927
Afterloading Recurrent cancer 1147 Cervical stump 933
HDR 1061 Cervix
Iridium-192 965 Cancer 87, 95, 1305
Afterloading technique 1229 Carcinoma 173, 921
Agents Cc Radiation therapy of carcinoma 81
Age response radiation 733 Charged particles 881
Cytostatic 295 Chemical sensitizers 147
Radiation-sensitizing 65 Cancer 739 Chemopotentiation 287
Alternating radiotherapy 1047 Anal canal 575 Chemotherapy 233, 243, 253, 303, 413, 651,
Amiloride 541 Base of tongue 965 953
Anal Bladder 233, 413 Resistance 197
Canal cancer 575 Breast 105, 177 Chemotherapy-radiotherapy
Preservation therapy 575 Cervical 667, 915 Combined 1183
Animal tumor model 1281 Cervix 87, 95, 1305 Chest wall 1147
Antenna(s) 531 Colon 203 Chordoma 761
Dipole 739 Early ovarian 939 Cisplatin 217, 221, 233, 271, 327, 347, 351,
Helical 739 Esophageal 29, 685, 875 1047, 1235
Anti-neoplastic drugs 213 Gynecologic 567 Cisplatinum 333
Antibody-toxic conjugates 65 Head and neck 13, 243, 357, 703, 1079, Clinical
Anticancer radiopharmaceutical 567 1369 Research 1383
Antioxidant enzymes 369 Incidental prostate 153 Clinical trials 1109
Antitumoral effect 347 Lung 217, 1183, 1369 Colon cancer 203
Arrhenius plots 751 Management 153 Combination chemotherapy-radiotherapy
Arteriovenous malformations 891 Non-small cell lung 945, 1047 1183
Association of residents in radiation Prostate 551 Combined
oncology (ARRO) 1363 Rat prostate 981 Effects 327
Astrocytomas Rectal 37 Therapy 343
Radiation therapy of 1309 Stage B-1 prostate 141 Combined chemotherapy-radiotherapy 1183
AVM 881 Stage III non-small cell lung 247 Combined modality(ies) 21, 29, 227, 253,
T3 laryngeal 1207 319, 413, 723
Vaginal 927 Therapy 239
Vaginal stump 927 Treatment 389, 1031
Canine 463 Compensators 127
BAL 973 Capacitive heating 1009 Complications 791, 1125, 147
Base of tongue cancer 965 Carboplatin 221, 1235 Radioactive chromic phosphate 939
BCNU 333 Carcinoembryonic antigen 203 Compounds
Beam’s-eye-view (BEV) planning 1317 Carcinoid 489 Platinum 1235
Beam(s) Carcinoma(s) 761, 1297 Computer
Electron 113, 853 Cervix 173, 921 CT planning 121
Non-axial 1309 C3H mammary 265 Graphics 843
Total skin electron 809 Endometrial 677 Concomitant prolonged infusion 357
Beta-glucuronidase 1263 Feline squamous cell 703 Concurrent radiation and chemotherapy 29
Bile duct 761 Glottic 1215 Conformal radiation therapy 141
Bladder cancer 413 Head and neck 21 Conformal therapy 1317
Bleomycin 339 Human squamous cell 315, 733 Contact effect 1243
Blood flow 1255 Incompletely excised skin basal cell 423 Continuous
Normal tissue 1001 Lung 7 Hyperfractionated accelerated
Tumor 259, 593, 1001 Non-small cell 351 radiotherapy (CHART) 581
Bone Oropharyngeal 1197 Infusion 351
Metastases 1297, 1369 Pancreatic 113 Control
Scintigraphy 1297 Prostate 1075 Local 1207
Bone marrow Prostatic 439 Corrections
Transplant 605 Rectal 351 Heterogeneity 1347
Transplantation 333, 397, 1219 Squamous cell 1235 Craniospinal 651
Crypt(s) Electrode H
Cell survival 227 Polarographic needle 1273
Jejunal 343 Electron
C3H mammary carcinoma 265 Dosimetry 1331 Hair follicles 997
Culture Isodose distributions 1331 HDR-afterloading 1061
Primary 1243 Electron arc therapy 1331 Head and neck 45
Curve Electron beam(s) 113, 853 Cancer 13, 243, 357, 703, 1079, 1369
Survival 1353 Total skin 809 Carcinoma 21
Cutaneous T-cell lymphoma 809 Electron boost 121 Neoplasms 101
Cyclophosphamide 311 Endometrial carcinoma 677 Heating
Cystectomy 233, 413 Ependymoma 781 Capacitive 1009
Cytostatic agents 295 Epidemiology 875 Deep 1009
Cytotoxic drugs 997 Epidermal growth factor 315 Step-down 1023
Cytotoxicity 59 Esophageal cancer 29, 685, 875 Heavy
Estrogen 1039 Charged particles 761
D Etanidazole (SR-2508) 703, 723, 987 Ions 689, 761
Etoposide 373 Helical antennas 739
Ewing’s sarcoma 389 Hemithorax irradiation 433
Daily treatment verification 613 External and intracavitary irradiation 173 Hemoglobin concentration 1197
Damage External beam Hepatoma 65, 953
DNA 377 Stereotactic irradiation 1325 Heterogeneity corrections 1347
Late 343 Extracellular pH 281 HFX 1191
Normal tissue 319, 1023 Eye High dose
Potentially lethal 509 Phantom 1087 Preoperative radiation therapy 37
Repair radiation 281 Plaques 1087 Rate brachytherapy 921, 927
Decision making 1369 High-LET 761
Deep Hip prosthesis 1093, 1347
Heating 1009 Histological differentiation 1197
Hyperthermia 1017, 1109 HT-29 207
Definitive Factor(s) Human
Breast irradiation 105 Epidermal growth 315 Carcinoma cells 751
Radiotherapy 95, 667 Growth 447 Sarcoma xenografts 1273
Delayed radiation injury 689 Prognostic 45, 405, 439, 667, 677 Squamous cell carcinoma 315, 733
Depth 1341 Fast neutrons 1341 Tumor 1255
Detoxification 197 Fat Hydralazine 1001
Dipole antennas 739 Perineal 1017 Hyperfractionation 555, 757
Dipyridamole 377 Subcutaneous 1009 Hyperglycaemia 1273
Disease Feline squamous cell carcinoma 703 Hyperoplastic liver nodules 361
Graft-versus-host 1219 Fibronectin 973 Hyperthermia 59, 479, 509, 531, 541, 551,
Locally advanced 1183 Field 723, 739, 751, 1009, 1031, 1039, 1099,
Distant metastases 21 Abutment 853 1147, 1255, 1273
DNA Gapping 853 Deep 1017, 1109
Damage 377 Filtered backprojection 859 Induced 1023
Repair 197 5-fluorodeoxyuridine 377 Interstitial 1117, 1281
Dose 1353 5-fluorouracil 239, 357, 377 Regional 73
Isoeffect 1353 Flunarizine 291 Whole body 525
Paracentral 87 Fluorodeoxyuridine 555 Hypoxia 221, 259, 265, 287, 723, 1031
Prescriptions 1067 Fluroinated 2-nitroimidazole 1249 Tumor 457
Rate 327 Focal irradiation 1309 Hypoxic cell(s) 147, 271
Uniformity 135 Fraction Acutely 709
Volume histogram(s) 555, 1309, 1325 Hypoxic 473, 709 Radiosensitizers 987, 1249
Dose response 1207 Size 429 Hypoxic fraction 473, 709
Dosimetry 135, 815, 859, 1087 Fractionated irradiation 311, 457, 709
Dosimetry Fractionation 1353
Electron 1331
Drug(s)
Anti-neoplastic 213 G IGF-1 655
Cytotoxic 997 IL-1 311
Resistance 213, 217 Induced hyperthermia 1023
Drug delivery Gamma knife 1287 incidental prostate cancer 153
Tumor-targeted 1263 Gastrointestinal morbidity 835 Incompletely excised basal cell carcinoma
DU-145 207 Glioma(s) 757 of skin 423
Intramedullary 781 Interaction(s) 221
E Metabolism 1053 Cell-cell 315
Glottic carcinoma 1215 Interfraction 1191
Glucuronosyltransferase 1263 Interleukin-1 (IL-1) 303, 307, 311, 447, 525
Early ovarian cancer 939 Glutathione 217 Interstitial 531, 739
Economic analysis 423 S-transferase 361 Hyperthermia 1117, 1281
Effect(s) Graft-versus-host disease 1219 Implant(s) 135, 621, 1079
Antitumoral 347 Growth Pneumonitis 397
Combined 327 Delay of tumor 227 Radiation 1281
Contact 1243 Hormone 655 Intestine and renal toxicity 347
Late 463 Growth factor(s) 447 Intra-abdominal/intraperitoneal 567
Oxygen 1243 Epidermal 315 Intracavitary
8-hydroxyquinoline 1263 Gynecologic cancer 567 Brachytherapy 927
Elapsed treatment days 13 Gynecological malignancy 1125 Irradiation 685
Radiation 667 Lung oO
Therapy 173 Cancer 217, 1183, 1369
Intracellular pH 281, 541 Carcinoma 7
Intramedullary glioma 781 Function 433 Odor 771
Intraoperative 113 Non-small cell carcinoma 351 Olfaction 771
Irradiation 463 Radiation-induced injury 973 Oncology
Radiotherapy 697 State III non-small cell cancer 247 Pediatric 1177
Intratumoral injections 703 Lymphoma(s) 803 On-line radiotherapy imaging 613
Inverted papilloma 777 Cutaneous T-cell 809 Optimization 859
In vivo 265, 1023 Non-Hodgkin’s 45, 791, 797 Oral small bowel contrast 835
i.p. administration 997 Orbit 791
lodine-125 1075 Oropharyngeal carcinoma 1197
Seeds 1087 Ovarian
lodine seeds 621 Transposition 1305
I-131 antibody 953 Magnetic resonance 881 Ovarian cancer 661
[I-123]iodo-estradiol 567 Imaging (MRI) 497, 689, 739, 799 Oxygen 147
Iproplatin 221 Malpractice 563 Effect 1243
Iridium-192 1079 Management of cancer 153 Partial pressure 1273
Afterloading 965 Mediastinum 7 Ozone 771
Irradiation 221, 429, 651, 757 Medulloblastoma 651, 897
Definitive breast 105 Melanoma 429 P
External and intracavitary 173 Mesothelioma 433
Focal 1309 Metastasis(es) 593
Fractionated 311, 457 Bone 1297, 1369 Palliative 1369
Fractionation 709 Brain 53, 1287 Pancreatic carcinoma 113
Hemithorax 433 Distant 21 Paracentral dose 87
Intracavitary 685 Microenvironmental heterogeneity 259 Paranasal sinus 761
Intraoperative 463 Microwave 531, 739 Neoplasms 777
Postoperative 21 Misonidazole 53, 1031 Paraspinal 787
Preoperative 21 Mitomycin 333 Partial pressure
Stereotactic external beam 1325 Mitomycin C 239, 259, 265 Oxygen 1273
Total body 333, 605, 1219 Model(s) Patient
Total nodal 809 Animal tumor 1281 Fixation 599
Whole abdominal 661 Linear-quadratic 181 Immobilization support 605
X 203 Predictive 419 Patterns of Care Study 105
Isoeffect dose 1353 Morbidity 581 Patterns of failure 87
Isotopes 787 Gastrointestinal 835 Pediatric
i.v. administration 997 Mouse 1023 Oncology 1177
Multicell spheroids 315 Radiation therapy 1177
J Multidrug resistance 361 Pelvic radiotherapy 1347
Muscle 463 Perineal fat 1017
Mutagenesis 213 Peripheral neuropathy 697
Jejunal crypts 343 PET 1053
N P-glycoprotein 361
K pH 259, 723, 1031, 1273
Acid 275
Nasal cavity 797 Dependence 59
Kaposi's sarcoma 419 Neoplasms 777 Extracellular 281
KHT sarcomas 497 Nasopharynx 823 Intracellular 281, 541
Kidney cell carcinoma 1243 Neoadjuvant 233 Pharmacokinetics 207
KU-2285 1249 Neon 761 Biodistribution 567
Neoplasm(s) 101 Pimonidazole (Ro 03-8799) 987
L Head and neck 101 Plasminogen activation 973
Nasal cavity 777 Platinum
Paranasal sinus 777 Compounds 1235
Lactate 275 Neuroblastoma 1177 Pneumonitis 227
Larynx 101 Neutrons Interstitial 397
Supraglottic 21 Fast 1341 pO, 1273
Late 327 New applicator 1061 Polarographic needle electrode 1273
Damages 343 Nicotinamide 291 Polymorphic reticulosis 797
Effects 463, 1191 Nigericin 281 Positron emission tomography (PET) 689
Lawsuits 563 Nitroimidazole 287 Postoperative
Leg 327 Non-axial beams 1309 Irradiation 21
Leucovorin 377 Non-Hodgkin’s lymphoma 45, 791, 797 Radiation therapy 945
Linear-quadratic model 181 Non-small cell lung Potentially lethal damage 509
Liver radiation 555 Cancer 945, 1047 Recovery (PLDR) 281
Local Carcinoma 351 Precooling 1009
Anesthetics 59 Normal tissue Predictive
Recurrence 551 Blood flow 1001 Assays 479, 733
Local control 1207 Damage 319, 1023 Models 419
Local tumor control 1197 Complication probability 823 Preoperative
Locally advanced disease 1183 Temperatures 1017 High dose radiation therapy 37
Lonidamine 509 Tissue tolerance 555 Irradiation 21
Low-dose(s) 221, 651 NSCLC 1183 Radiation therapy 37
Craniospinal treatment 897 NSD 1207, 1353 Radio-chemotherapy 239
Rate 181 Nursing exposure 627 Pretreatment prognostic factors 247
LQ-model 1207 Nutrient status 373 Primary culture 1243
Probability Radiobiology 715 R3327-MATLyLu 981
Normal tissue complication 823 Radiohalogenated sex steroid 567 RTOG 7
Tumor control 823 Radioimmunotherapy 715
Process survey 105 Radiology 101 S
Procollagen-III 973 Radioprotection 307, 369, 447
Professional liability 563 Radioprotector 525
Prognosis 65 Radioresistance 343 Salivary gland 761
Prognostic Radiosensitivity 217, 981 Salvage
Factors 45, 405, 439, 667, 677 Kidney cell 1243 Surgery 581
Parameters 1147 Radiosensitization 147, 207, 243, 457, 1031 Therapy 965
Pretreatment factors 247 Radiosensitizer(s) 291, 377 SAR 739
Prolactin 655 Hypoxic cell 987, 1249 Sarcoma(s) 587, 593, 761
Proliferation 373 Radiosurgery 517, 891, 1287, 1325 Bone 761
Tumor 295 Stereotactic 881 Ewing’s 389
Prostate 761 Radiotherapy 45, 65, 177, 213, 233, 243, Kaposi's 419
Cancer 551 253, 347, 419, 497, 517, 563, 575, KHT 497
Carcinoma 1075 587, 651, 655, 685, 757, 761, 771, Recurrent 1229
Incidental cancer 153 835, 875, 1093, 1125, 1191, 1197, Soft-tissue 405, 761
Stage B-1 141 1215, 1297, 1369 Xenografts, human 1273
Prostate culture 1317 Alternating 1047 SCC VII
Prostate movement 1317 Continuous hyperfractionated Murine tumor 271
Prostatic carcinoma 439 accelerated 581 Tumor 709
Prosthesis Definitive 95, 667 Scintigraphy
Hip 1347 Intraoperative 697 Bone 1297
Protection 303, 627 On-line imaging 613 Score functions 1067
Protein kinase C 1039 Pelvic 1347 Second primary 21
P-31 MRS 291 Stereotactic 599, 1053 Seeds
P-32 661 Thoracic 1183 Iodine 621
Pulmonary fibrosis 227 Radiotherapy technique 1215 lodine-125 1087
Pulmonary function 1219 Radon transform 859 Sensitization 221
Randomized Sensitizer(s)
Q Study 21 Chemical 147
Trials 233 Radiation 555
Randomized trial 1183 Sex 1197
Quality Rat Simulation 835
Assurance 517, 1099, 1109, 1117 Prostate cancer 981 6 MeV X rays 1215
Control review 13 Rhabdomyosarcoma tumors 473 Skin 327, 1023
Rectal Incompletely excised basal cell
R Cancer 37 carcinoma 423
Carcinoma 351 SLD 1235
Recurrence 587 Soft-tissue sarcomas 405, 761
R.B.E. 1341 Local 551 Solid tumors 275
Rabbits 689 Vaginal stump 927 Spermatogonia 339
Radiation 259, 265, 303, 327, 339, 343, 509, Recurrent Spheroids 1235
787 Breast cancer 1147 Spinal cord tumor 781
Age response 733 Cervical cancer 927 Squamous cell 21
Damage repair 281 Sarcoma 1229 Carcinoma 1235
Delayed injury 689 Regional Feline carcinoma 703
Interstitial 1281 Hyperthermia 73 SR 4233 457
Intracavitary 667 Nodes 7 SR-2508 703, 723, 987
Liver 555 Regrowth delay 265 Stage
Nephritis 333 Reirradiation 1147 B-1 prostate cancer 141
Oncology 105 Relapse 397 III non-small cell lung cancer 247
Resistance 197 Remote afterloading intracavitary therapy III-B 95
Response 315 921 Step-down heating 1023
Safety 627 Research Stereotactic 517
Sensitizer 555 Clinical 1383 Angiography 891
Sensitizing agents 65 Resident survey 1363 Frame 599
Therapy 1305 Reoxygenation 473, 709 Radiosurgery 881
Radiation-induced lung injury 973 Repair Radiotherapy 599, 1053
Radiation therapy (RT) 7, 53, 87, 113, 147, DNA 197 Stereotactic external beam irradiation 1325
153, 295, 357, 413, 423, 439, 489, Radiation damage 281 Stereotaxis 891
551, 563, 593, 777, 781, 791, 797, Resistance Subcutaneous fat 1009
803, 815, 859, 897, 933, 1207 Chemotherapy 197 Succinate 275
Carcinoma of the cervix 81 Drug 217 Supra-additivity 227
Conformal 141 Multidrug 361 Supraglottic larynx 21
High dose preoperative 37 Radiation 197 Surgery 933
of astrocytomas, 1309 Xenobiotic 361 Surgical
Pediatric 1177 Response Axis 121
Postoperative 945 Dose 1207 Clips 121
Preoperative 37 Review 253 Survey
Radiation Therapy Oncology Group 1383 Rhabdomyosarcoma 1177, 1281 Resident 1363
Radiation treatment high dose rate 915 RIF tumor cells 1263 Survival 87, 1341
Radical 1369 Rodent cells 751 Crypt cell 227
Radical hysterectomy 677 Ro 03-8799 987 Curve 1353
Radioactive chronic phosphate RT 1191 Curve parameters 203
complications 939 R3327-AT 981 Symptoms 771
Titanium dose distortions 1093 Tumor-targeted drug delivery 1263
Tl 497 T2 497
Topoisomerases 197 2-nitroimidazole 1249
Tl 1215 Total Fluorinated 1249
T3 laryngeal cancer 1207 Body irradiation (TBI) 333, 525, 605, U
Tamoxifen 1039 1219
TBI fractionation 397 Nodal irradiation 809
Technique(s) 621 Skin electron beam 809
Ultrasound 1099
Afterloading 1229 Tracheobronchial tumors 1061
URDT 1191
Radiotherapy 1215 Transitional cell carcinoma 413
Uterine cervix 933
Stereotactic 1287 Transposition
Carcinoma 81
Tetraplatin 221 Ovarian 1305
Therapeutic 101 Treatment Vv
Gain 227, 319 Combined modality 389, 1031
Therapy Daily verification 613
Adjuvant 21 Low-dose craniospinal 897 Vaginal cancer 927
Anal preservation 575 Uncertainties 613 Vaginal stump
Combined 343 Treatment planning 177, 823, 843, 881, Cancer 927
Combined modality 239 1067, 1325, 1347 Recurrence 927
Conformal 1317 Computerized three-dimensional 1317 Vincristine 339, 369
Electron arc 1331 Three-dimensional 127, 1309 V79 cells 221
Intracavitary 173 Three-dimensional computerized beam’s V79 Chinese hamster cells 1341
Radiation 7, 53, 87, 113, 147, 153, 295, eye view 141 Volume
357, 413, 423, 439, 489, 551, 563, Treatment sequence 1235 Tumor 1197
593, 777, 781, 791, 797, 803, 859, Treatment time 1197
897, 933, 1207, 1305 Tumor(s) 987, 1273 Ww
Remote afterloading intracavitary 921 Blood flow 259, 593, 1001
Salvage 965 Brain 757, 815, 1053, 1287
Thermal Growth delay 227 Waldeyer’s ring 45
Enhancement ratio 751 Heterogeneity 479 Water content 497
Parameters 1147 Human 1255 Whole
Thermoluminescent dosimetry (TLD) 1347 Hypoxia 457 Abdominal irradiation 661
Thermometry 1099, 1117 Local control 1197 Body hyperthermia 525
Thermo-radiosensitization 751 Microenvironment 253
Thermoresistance 1039 Proliferation 295
Thermosensitivity 541 Rat rhabdomyosarcoma 473
Thermosensitization 1023 SCC VII 709 Xenobiotic resistance 361
Thermotolerance 479, 1023 SCCVII murine 271 X irradiation 203
Thoracic radiotherapy 1183 Solid 275 X rays 271
Three-dimensional 823 Spinal cord 781 6 MeV 1215
Computerized beam’s eye view Tracheobronchial 1061 Xenograft(s)
treatment planning 141 Tumor-bearing mice 307 Human sarcoma 1273
Displays 843 Tumor cell(s)
Treatment planning 127 RIF 1263 Y
Three-dimensional treatment planning 1309 Tumor control 265, 1147
Computerized 1317 Probability 823
Time 1353 Tumor volume 1197 Yttrium-90 715